IBDEI22M ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2009,0)
 ;;=WOUNDS^36^182
 ;;^UTILITY(U,$J,358.4,2010,0)
 ;;=COMA^7^182
 ;;^UTILITY(U,$J,358.4,2011,0)
 ;;=CAUSES OF INJURY^6^182
 ;;^UTILITY(U,$J,358.4,2012,0)
 ;;=AMPUTATION STATUS^1^183
 ;;^UTILITY(U,$J,358.4,2013,0)
 ;;=BRAIN DISORDERS^2^183
 ;;^UTILITY(U,$J,358.4,2014,0)
 ;;=CARDIOPULMONARY^4^183
 ;;^UTILITY(U,$J,358.4,2015,0)
 ;;=COMPLICATIONS DUE TO^5^183
 ;;^UTILITY(U,$J,358.4,2016,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^11^183
 ;;^UTILITY(U,$J,358.4,2017,0)
 ;;=Z CODES^16^183
 ;;^UTILITY(U,$J,358.4,2018,0)
 ;;=BRAIN INJURY - TRAUMATIC^3^183
 ;;^UTILITY(U,$J,358.4,2019,0)
 ;;=FEMUR/THIGH/KNEE FRACTURE^6^183
 ;;^UTILITY(U,$J,358.4,2020,0)
 ;;=FOOT/TOE/ANKLE FRANCTURE^7^183
 ;;^UTILITY(U,$J,358.4,2021,0)
 ;;=HAND/FINGER FRACTURE^8^183
 ;;^UTILITY(U,$J,358.4,2022,0)
 ;;=HIP/PELVIS FRACTURE^9^183
 ;;^UTILITY(U,$J,358.4,2023,0)
 ;;=HUMERUS/SHOULDER FRACTURE^10^183
 ;;^UTILITY(U,$J,358.4,2024,0)
 ;;=TIBIA/FIBULA FRACTURE^14^183
 ;;^UTILITY(U,$J,358.4,2025,0)
 ;;=SPINE FRACTURE^13^183
 ;;^UTILITY(U,$J,358.4,2026,0)
 ;;=WRIST/FOREARM FRACTURE^15^183
 ;;^UTILITY(U,$J,358.4,2027,0)
 ;;=OTHER FRACTURE^12^183
 ;;^UTILITY(U,$J,358.4,2028,0)
 ;;=PRIMARY DIAGNOSES CODES^1^184
 ;;^UTILITY(U,$J,358.4,2029,0)
 ;;=PULMONARY DIAGNOSES^1^185
 ;;^UTILITY(U,$J,358.4,2030,0)
 ;;=SLEEP DX PRELIMINARY^2^185
 ;;^UTILITY(U,$J,358.4,2031,0)
 ;;=SLEEP DX CONFIRMED^3^185
 ;;^UTILITY(U,$J,358.4,2032,0)
 ;;=DEVELOPMENTAL DISORDERS^1^186
 ;;^UTILITY(U,$J,358.4,2033,0)
 ;;=LATE EFFECTS OF CEREBROVASCULAR DISEASE^2^186
 ;;^UTILITY(U,$J,358.4,2034,0)
 ;;=VOCAL FOLD DISORDERS^3^186
 ;;^UTILITY(U,$J,358.4,2035,0)
 ;;=SWALLOWING DISORDERS^4^186
 ;;^UTILITY(U,$J,358.4,2036,0)
 ;;=SPEECH DISORDERS^5^186
 ;;^UTILITY(U,$J,358.4,2037,0)
 ;;=REASON FOR VISIT/HEALTH STATUS^6^186
 ;;^UTILITY(U,$J,358.4,2038,0)
 ;;=TBI SCREENING^1^187
 ;;^UTILITY(U,$J,358.4,2039,0)
 ;;=MENTAL HEALTH^4^187
 ;;^UTILITY(U,$J,358.4,2040,0)
 ;;=NEUROLOGY^5^187
 ;;^UTILITY(U,$J,358.4,2041,0)
 ;;=HEADACHES^2^187
 ;;^UTILITY(U,$J,358.4,2042,0)
 ;;=HISTORY OF ILLNESS^3^187
 ;;^UTILITY(U,$J,358.4,2043,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^6^187
 ;;^UTILITY(U,$J,358.4,2044,0)
 ;;=CAUSES OF INJURY (SECONDARY DX ONLY)^7^187
 ;;^UTILITY(U,$J,358.4,2045,0)
 ;;=GENERAL SIGNS & SYMPTOMS^3^188
 ;;^UTILITY(U,$J,358.4,2046,0)
 ;;=AFTERCARE POST-OP^1^188
 ;;^UTILITY(U,$J,358.4,2047,0)
 ;;=POST-OP COMPLICATIONS^5^188
 ;;^UTILITY(U,$J,358.4,2048,0)
 ;;=CARDIOVASCULAR^2^188
 ;;^UTILITY(U,$J,358.4,2049,0)
 ;;=RESPIRATORY^6^188
 ;;^UTILITY(U,$J,358.4,2050,0)
 ;;=NEOPLASM^4^188
 ;;^UTILITY(U,$J,358.4,2051,0)
 ;;=CHRONIC PULM. HEART DISEASE^1^189
 ;;^UTILITY(U,$J,358.4,2052,0)
 ;;=DIS. OF BLOOD/FORMING ORGA^3^189
 ;;^UTILITY(U,$J,358.4,2053,0)
 ;;=HERNIA^5^189
 ;;^UTILITY(U,$J,358.4,2054,0)
 ;;=KIDNEY/PANCREAS^6^189
 ;;^UTILITY(U,$J,358.4,2055,0)
 ;;=LIVER^7^189
 ;;^UTILITY(U,$J,358.4,2056,0)
 ;;=LUNG^8^189
 ;;^UTILITY(U,$J,358.4,2057,0)
 ;;=MALIGNANT LYMPH & HEMATOP^9^189
 ;;^UTILITY(U,$J,358.4,2058,0)
 ;;=MALIGNANT NEOPLASMS SOLID ORGANS^10^189
 ;;^UTILITY(U,$J,358.4,2059,0)
 ;;=METABOLIC DISORDERS^11^189
 ;;^UTILITY(U,$J,358.4,2060,0)
 ;;=SYMPTOMS/SIGNS^12^189
 ;;^UTILITY(U,$J,358.4,2061,0)
 ;;=COMPLICATIONS OF SURGERY^2^189
 ;;^UTILITY(U,$J,358.4,2062,0)
 ;;=DONORS OF ORGANS AND TISSUES^4^189
 ;;
 ;;$END ROU IBDEI22M
